EMCURE PHARMACEUTICALS L (EMCURE.NS)
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
1,960.10+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+43.7%
The outlook
EMCURE PHARMACEUTICALS L currently reads as bullish based on strong buy — 1.4 avg of 7 analysts, above its 50- & 200-day averages, 95% of the way from its 52-week low to high, avg target +0% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 7 analysts
Price trendAbove its 50- & 200-day averages
52-week range95% of the way from its 52-week low to high
Price targetAvg target +0% vs current price
Analyst price target
~12-month · 7 analysts1,963.00average target+0.1% vs now
Now 1,960.10
Low 1,640.00High 2,260.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$371.79B
52-wk high
1,999.00
52-wk low
1,260.00
50-day avg
1,795.76
200-day avg
1,572.61
Trailing P/E
40.2